PubRank

Hydroxychloroquine to Improve Insulin Sensitivity in Rheumatoid Arthritis (RA PLUS)

Clinical Trial ID NCT01132118

PubWeight™ 1.61‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01132118

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 26.39
2 Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003 6.62
3 Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005 4.63
4 Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001 4.31
5 The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001 3.58
6 Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002 2.92
7 Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford) 2006 2.54
8 Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA 2007 2.17
9 Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 2005 2.11
10 Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 2004 1.69
11 Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum 2008 1.63
12 Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 2004 1.62
13 Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 2006 1.38
14 The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trial. Diabetes Res Clin Pract 2002 1.17
15 Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? Ann Intern Med 1990 1.14
16 Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol 1995 0.96
17 Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats. Life Sci 1999 0.90
18 Insulin binding and degradation in isolated hepatocytes from streptozotocin injected rats. Biochem Biophys Res Commun 1985 0.87
19 Effect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial. Arthritis Care Res (Hoboken) 2014 0.81
20 The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis 2015 0.80
21 Is there a role for chloroquine treatment in diabetes? A three case report. Diabete Metab 1989 0.79
Next 100